Cargando…

Mucosal vaccines and technology

There is an urgent and unmet need to develop effective vaccines to reduce the global burden of infectious disease in both animals and humans, and in particular for the majority of pathogens that infect via mucosal sites. Here we summarise the impediments to developing mucosal vaccines and review the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miquel‐Clopés, A., Bentley, E. G., Stewart, J. P., Carding, S. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Vaccines for Emerging Pathogens: from Research to the Clinic. Part 1. Series Editor: E Diane Williamson
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468177/ https://www.ncbi.nlm.nih.gov/pubmed/30963541 http://dx.doi.org/10.1111/cei.13285

Ejemplares similares

Novel approaches for the design, delivery and administration of vaccine technologies
por: Wallis, J., et al.
Publicado: (2019)

HLA‐E: exploiting pathogen‐host interactions for vaccine development
por: Sharpe, H. R., et al.
Publicado: (2019)

Emerging viruses and current strategies for vaccine intervention
por: Afrough, B., et al.
Publicado: (2019)

Vaccines for emerging pathogens: from research to the clinic
por: Williamson, E. D.
Publicado: (2019)

Formulation technologies for oral vaccines
por: New, R. R. C.
Publicado: (2019)

Vaccines for emerging pathogens: prospects for licensure
por: Williamson, E. D., et al.
Publicado: (2019)

A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens
por: Abraham, A., et al.
Publicado: (2019)

Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20–64 years, 2007–2011
por: Kelly, Heath A., et al.
Publicado: (2012)

Advances in the development of universal influenza vaccines
por: Gilbert, Sarah C.
Publicado: (2012)

Comparative safety, immunogenicity, and efficacy of several anti‐H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine)
por: Gambaryan, Alexandra S., et al.
Publicado: (2011)

Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza
por: Vodeiko, Galina M., et al.
Publicado: (2011)

No evidence of a link between influenza vaccines and Guillain–Barre syndrome–associated antiganglioside antibodies
por: Wang, David J., et al.
Publicado: (2011)

The potential economic value of a ‘universal’ (multi‐year) influenza vaccine
por: Lee, Bruce Y., et al.
Publicado: (2011)

A plant‐based system for rapid production of influenza vaccine antigens
por: Shoji, Yoko, et al.
Publicado: (2011)

Safety and tolerability of a 2009 trivalent inactivated split‐virion influenza vaccine in infants, children and adolescents
por: Lambert, Stephen B., et al.
Publicado: (2013)

Protective efficacy of crude virus‐like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy
por: Park, Jae‐Keun, et al.
Publicado: (2012)

Virus detection and its association with symptoms during influenza‐like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trial
por: Howard, Peter F., et al.
Publicado: (2012)

Experience of Treating Candida auris Cases at a General Hospital in Qatar
por: Shaukat, Adila, et al.
Publicado: (2021)

Healthcare personnel with laboratory-confirmed mpox in California
por: Bailey, Allison, et al.
Publicado: (2023)

Mpox exposure on a congregate inpatient psychiatry unit: Description of the investigation and outcomes—New York City, 2022
por: Malik, Waleed, et al.
Publicado: (2023)

Genetic relatedness among Neisseria gonorrhoeae isolates in southeastern Michigan
por: Shallal, Anita, et al.
Publicado: (2023)

Alarming prevalence of Candida auris among critically ill patients in intensive care units in Dhaka City, Bangladesh
por: Chowdhury, Fahmida, et al.
Publicado: (2023)

Molecular epidemiology of meningococcal disease in England and Wales 1975–1995, before the introduction of serogroup C conjugate vaccines
por: Russell, Joanne E., et al.
Publicado: (2008)

Many ways to make an influenza virus – review of influenza virus reverse genetics methods
por: Engelhardt, Othmar G.
Publicado: (2012)

Sentinel surveillance for influenza and other respiratory viruses in Côte d’Ivoire, 2003–2010
por: Kadjo, Hervé A., et al.
Publicado: (2012)

Relationship between community prevalence of obesity and associated behavioral factors and community rates of influenza‐related hospitalizations in the United States
por: Charland, Katia M., et al.
Publicado: (2012)

Isolation and characterization of H3N8 equine influenza A virus associated with the 2011 epizootic in Mongolia
por: Yondon, Myagmarsukh, et al.
Publicado: (2013)

The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy
por: Van Kerkhove, Maria D., et al.
Publicado: (2012)

Progressive emergence of an oseltamivir‐resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient
por: Hurt, Aeron C., et al.
Publicado: (2013)

Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings
por: Burns, Jane L., et al.
Publicado: (2011)

Inter‐ and intraspecies transmission of canine influenza virus (H3N2) in dogs, cats, and ferrets
por: Kim, Hyekwon, et al.
Publicado: (2012)

Strain-dependent induction of epithelial cell oncosis by Campylobacter jejuni is correlated with invasion ability and is independent of cytolethal distending toxin
por: Kalischuk, Lisa D., et al.
Publicado: (2007)

Influenza Research Database: an integrated bioinformatics resource for influenza research and surveillance
por: Squires, R. Burke, et al.
Publicado: (2012)

Advantage of meditation over exercise in reducing cold and flu illness is related to improved function and quality of life
por: Obasi, Chidi N., et al.
Publicado: (2012)

A statistical strategy to identify recombinant viral ribonucleoprotein of avian, human, and swine influenza A viruses with elevated polymerase activity
por: Chin, Alex W. H., et al.
Publicado: (2013)

Parenteral fluids do not affect pulmonary immune responses to influenza or susceptibility to secondary bacterial pneumonia in mice
por: Sanders, Robert D., et al.
Publicado: (2012)

Amaryllidaceae alkaloids inhibit nuclear‐to‐cytoplasmic export of ribonucleoprotein (RNP) complex of highly pathogenic avian influenza virus H5N1
por: He, Jun, et al.
Publicado: (2012)

Report of the first Asia–Pacific Forum on antiviral treatment of influenza, Asia–Pacific Alliance for the Control of Influenza, Bangkok, 14 June 2012
por: Jennings, Lance C., et al.
Publicado: (2013)

Comparing the use of, and considering the need for, lumbar puncture in children with influenza or other respiratory virus infections
por: Khandaker, Gulam, et al.
Publicado: (2012)

Infection with influenza A viruses causes changes in promoter DNA methylation of inflammatory genes
por: Mukherjee, Sanjay, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_h5t2g04rjm4fjj5v19gh8om683